loading

Finanzdaten der Iteos Therapeutics Inc-Aktie (ITOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 35.00
Operating Expenses
109.37%
83.79
40.02 49.33 48.80 49.17
Depreciation and Amortization
21.33%
0.364
0.30 0.322 0.30 0.30
Operating Income/Loss
109.37%
-83.79
-40.02 -49.33 -48.80 -14.17
Income/Loss From Continuing Operations Before Tax
129.94%
-77.06
-33.51 -36.36 -43.12 -4.867
Income Tax Expense/Benefit
51.82%
1.67
1.10 7.355 2.243 2.261
Income/Loss From Continuing Operations After Tax
127.46%
-78.73
-34.61 -43.71 -45.36 -7.128
Net Income/Loss
127.46%
-78.73
-34.61 -43.71 -45.36 -7.128
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.75%
43.56
43.24 0.9017 43.14 39.70
Diluted Average Shares
0.75%
43.56
43.24 0.9017 43.14 39.70
Basic Earnings Per Share
126.25%
-1.81
-0.80 -1.03 -1.05 -0.18
Diluted Earnings Per Share
126.25%
-1.81
-0.80 -1.03 -1.05 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.12
price up icon 1.34%
$83.87
price down icon 1.17%
$24.65
price down icon 0.52%
$101.77
price down icon 1.19%
$135.09
price up icon 0.45%
biotechnology ONC
$299.75
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):